[Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
D000990:Antithrombin III / Q000032:analysis*; D002863:Chromogenic Compounds; D004151:Dipeptides; D005069:Evaluation Studies as Topic; D005260:Female; D005341:Fibrinolysin / Q000037:antagonists & inhibitors*; D006801:Humans; D009842:Oligopeptides; D011247:Pregnancy
D002863:Chromogenic Compounds; D004151:Dipeptides; D009842:Oligopeptides; C018788:valyl-leucyl-lysine 4-nitroanilide; C021129:S 2238; D000990:Antithrombin III; D005341:Fibrinolysin